IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 90 filers reported holding IRADIMED CORP in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $207 | -31.0% | 4,345 | -43.1% | 0.02% | -34.3% |
| Q1 2023 | $300 | -99.9% | 7,630 | -7.0% | 0.04% | +20.7% |
| Q4 2022 | $231,978 | -5.7% | 8,200 | 0.0% | 0.03% | -9.4% |
| Q3 2022 | $246,000 | -11.5% | 8,200 | 0.0% | 0.03% | -8.6% |
| Q2 2022 | $278,000 | -24.5% | 8,200 | 0.0% | 0.04% | -7.9% |
| Q1 2022 | $368,000 | -8.5% | 8,200 | -5.7% | 0.04% | -2.6% |
| Q4 2021 | $402,000 | +19.6% | 8,700 | -13.0% | 0.04% | +8.3% |
| Q3 2021 | $336,000 | +9.8% | 10,000 | -3.9% | 0.04% | +12.5% |
| Q2 2021 | $306,000 | +14.2% | 10,409 | 0.0% | 0.03% | +6.7% |
| Q1 2021 | $268,000 | +13.1% | 10,409 | 0.0% | 0.03% | +3.4% |
| Q4 2020 | $237,000 | +6.3% | 10,409 | 0.0% | 0.03% | -6.5% |
| Q3 2020 | $223,000 | -7.9% | 10,409 | 0.0% | 0.03% | -13.9% |
| Q2 2020 | $242,000 | +9.0% | 10,409 | 0.0% | 0.04% | -7.7% |
| Q1 2020 | $222,000 | -25.8% | 10,409 | -18.5% | 0.04% | +2.6% |
| Q4 2019 | $299,000 | +11.6% | 12,771 | 0.0% | 0.04% | +2.7% |
| Q3 2019 | $268,000 | +2.7% | 12,771 | 0.0% | 0.04% | +5.7% |
| Q2 2019 | $261,000 | -27.3% | 12,771 | 0.0% | 0.04% | -28.6% |
| Q1 2019 | $359,000 | +15.1% | 12,771 | 0.0% | 0.05% | 0.0% |
| Q4 2018 | $312,000 | -46.5% | 12,771 | -18.6% | 0.05% | -37.2% |
| Q3 2018 | $583,000 | +6.0% | 15,687 | -40.8% | 0.08% | +1.3% |
| Q2 2018 | $550,000 | +15.8% | 26,500 | -19.7% | 0.08% | +10.0% |
| Q1 2018 | $475,000 | -5.0% | 33,000 | 0.0% | 0.07% | -2.8% |
| Q4 2017 | $500,000 | +57.7% | 33,000 | 0.0% | 0.07% | +50.0% |
| Q3 2017 | $317,000 | +11.6% | 33,000 | 0.0% | 0.05% | +6.7% |
| Q2 2017 | $284,000 | +6.4% | 33,000 | +10.0% | 0.04% | +2.3% |
| Q1 2017 | $267,000 | +20.3% | 30,000 | +50.0% | 0.04% | +15.8% |
| Q4 2016 | $222,000 | -6.7% | 20,000 | +42.9% | 0.04% | -9.5% |
| Q3 2016 | $238,000 | -8.8% | 14,000 | +16.7% | 0.04% | -17.6% |
| Q2 2016 | $261,000 | +13.5% | 12,000 | 0.0% | 0.05% | +10.9% |
| Q1 2016 | $230,000 | -17.9% | 12,000 | +20.0% | 0.05% | -19.3% |
| Q4 2015 | $280,000 | -39.5% | 10,000 | -47.4% | 0.06% | -45.7% |
| Q3 2015 | $463,000 | +4.8% | 19,000 | 0.0% | 0.10% | +14.1% |
| Q2 2015 | $442,000 | +52.9% | 19,000 | 0.0% | 0.09% | +48.4% |
| Q1 2015 | $289,000 | +18.0% | 19,000 | 0.0% | 0.06% | +10.7% |
| Q4 2014 | $245,000 | +105.9% | 19,000 | +11.8% | 0.06% | +93.1% |
| Q3 2014 | $119,000 | – | 17,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 140,752 | $3,290,000 | 3.17% |
| RK Capital | 222,914 | $5,212,000 | 1.95% |
| Nine Ten Capital Management LLC | 130,272 | $3,046,000 | 0.76% |
| Parkman Healthcare Partners LLC | 93,500 | $2,186,000 | 0.63% |
| Ranger Investment Management | 244,963 | $5,727,000 | 0.38% |
| CADENCE CAPITAL MANAGEMENT LLC | 107,043 | $2,503,000 | 0.27% |
| ALGERT GLOBAL LLC | 29,652 | $693,000 | 0.21% |
| Mondrian Investment Partners LTD | 163,939 | $3,833,000 | 0.10% |
| NAVELLIER & ASSOCIATES INC | 20,800 | $486,000 | 0.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 56,811 | $1,328,000 | 0.04% |